CRSP RSI Chart
Last 7 days
-0.9%
Last 30 days
-16.8%
Last 90 days
-22.5%
Trailing 12 Months
-15.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 697.5M | 588.7M | 480.0M | 371.2M |
2022 | 806.2M | 0 | 0 | 0 |
2021 | 646.9M | 736.3M | 825.6M | 915.0M |
2020 | 0 | 378.9M | 468.3M | 557.6M |
2019 | 2.1M | 97.9M | 193.8M | 289.6M |
2018 | 31.5M | 22.1M | 12.6M | 3.1M |
2017 | 7.4M | 10.2M | 11.0M | 41.0M |
2016 | 1.2M | 2.1M | 3.1M | 5.2M |
2015 | 0 | 0 | 0 | 247.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 15, 2024 | kulkarni samarth | acquired | 374,408 | 19.12 | 19,582 | chief executive officer |
Apr 15, 2024 | kulkarni samarth | sold | -1,173,230 | 59.9138 | -19,582 | chief executive officer |
Mar 15, 2024 | kulkarni samarth | acquired | 764,800 | 19.12 | 40,000 | chief executive officer |
Mar 15, 2024 | kulkarni samarth | sold | -2,899,260 | 72.4814 | -40,000 | chief executive officer |
Mar 15, 2024 | prasad raju | sold | -256,160 | 72.69 | -3,524 | chief financial officer |
Mar 14, 2024 | prasad raju | acquired | - | - | 10,000 | chief financial officer |
Mar 12, 2024 | kulkarni samarth | sold | -341,159 | 74.44 | -4,583 | chief executive officer |
Mar 12, 2024 | kasinger james r. | sold | -85,308 | 74.44 | -1,146 | general counsel and secretary |
Mar 11, 2024 | kulkarni samarth | acquired | - | - | 9,000 | chief executive officer |
Mar 11, 2024 | kulkarni samarth | sold | -767,104 | 78.26 | -9,802 | chief executive officer |
Which funds bought or sold CRSP recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 07, 2024 | NEW YORK STATE COMMON RETIREMENT FUND | unchanged | - | 7,000 | 84,000 | -% |
May 07, 2024 | CarsonAllaria Wealth Management, Ltd. | added | 5.57 | 3,864 | 29,718 | 0.02% |
May 07, 2024 | Reynders McVeigh Capital Management, LLC | added | 5.36 | 849,000 | 6,611,000 | 0.38% |
May 07, 2024 | Swiss National Bank | added | 0.13 | 840,404 | 10,149,000 | 0.01% |
May 07, 2024 | Strengthening Families & Communities, LLC | sold off | - | - | - | -% |
May 07, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -66.26 | -8,598,310 | 4,991,900 | -% |
May 07, 2024 | Legacy Capital Group California, Inc. | reduced | -2.6 | 47,893 | 839,595 | 0.31% |
May 07, 2024 | Susquehanna Portfolio Strategies, LLC | reduced | -48.44 | -1,984,920 | 2,540,870 | 0.06% |
May 07, 2024 | SYNTAX RESEARCH, INC. | unchanged | - | 1,390 | 17,040 | 0.01% |
May 07, 2024 | SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | new | - | 1,601,960 | 1,601,960 | 0.07% |
Unveiling CRISPR Therapeutics AG's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to CRISPR Therapeutics AG)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 46.7B | 6.8B | -7.83 | 6.82 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.3B | 2.0B | -58.01 | 9.62 | ||||
BMRN | 15.5B | 2.5B | 75.6 | 6.28 | ||||
INCY | 12.0B | 3.8B | 16.12 | 3.19 | ||||
MID-CAP | ||||||||
BBIO | 5.2B | 107.9M | -9.48 | 48.09 | ||||
APLS | 5.1B | 524.1M | -12.3 | 9.8 | ||||
AXSM | 3.6B | 251.0M | -12.13 | 14.32 | ||||
ARWR | 3.1B | 240.7M | -10.53 | 12.18 | ||||
ACAD | 2.8B | 726.4M | -46.06 | 3.89 | ||||
SMALL-CAP | ||||||||
CPRX | 1.7B | 411.3M | 26.68 | 4.22 | ||||
NVAX | 625.6M | 983.7M | -1.15 | 0.64 | ||||
CRBP | 451.6M | 881.7K | -13.38 | 481.06 | ||||
INO | 257.1M | 4.9M | -1.9 | 52.83 | ||||
IBIO | 6.6M | 2.1M | -0.24 | 2.14 |
CRISPR Therapeutics AG News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Revenue | -100.0% | - | 201,206,000 | - | 70,000,000 | 100,000,000 | 56,449,500 | 12,899,000 | 824,000 | 900,701,000 | 735,964,000 | 571,227,000 | 406,490,000 | 241,753,000 | 77,016,000 | 211,928,000 | 106,128,000 | 328,000 | 115,000 | 563,000 | 1,088,000 | 16,706,500 |
Operating Expenses | 7.2% | 141,091,000 | 131,623,000 | 132,411,000 | 165,223,000 | 164,487,000 | 176,912,000 | 158,597,000 | 129,673,000 | 138,083,000 | 115,082,000 | 108,131,000 | 92,547,000 | 80,733,000 | 66,033,000 | 72,765,000 | 55,301,000 | 48,751,000 | 45,343,000 | 49,995,000 | 38,374,000 | - |
S&GA Expenses | -100.0% | - | 16,479,000 | 18,291,000 | 19,032,000 | 22,360,000 | 28,021,000 | 23,168,000 | 23,709,000 | 28,806,000 | 24,517,000 | 23,305,000 | 21,539,000 | 21,353,000 | 17,272,000 | 15,519,000 | 15,768,000 | 14,929,000 | 16,542,000 | 10,175,000 | 12,741,000 | 8,836,000 |
R&D Expenses | -19.9% | 76,172,000 | 95,144,000 | 90,698,000 | 101,555,000 | 99,935,000 | 118,245,000 | 103,605,000 | 83,500,000 | 82,332,000 | 70,620,000 | 36,801,000 | 71,008,000 | 59,380,000 | 48,761,000 | 57,246,000 | 39,533,000 | 33,822,000 | 28,801,000 | 39,820,000 | 25,633,000 | - |
EBITDA Margin | -49.2% | -0.53 | -0.35 | -0.71 | -0.68 | -0.72 | 0.42 | 0.43 | 0.52 | 0.63 | - | - | - | - | - | - | - | - | - | - | - | - |
Income Taxes | 215.3% | 700,000 | 222,000 | 412,000 | 900,000 | 1,320,000 | 3,600,000 | -2,232,500 | -595,000 | 4,100,000 | 600,000 | -169,000 | 200,000 | 400,000 | 26,000 | 274,000 | 85,000 | 85,000 | 234,000 | 137,000 | 96,000 | - |
Earnings Before Taxes | -229.3% | -115,867,000 | 89,580,000 | -111,740,000 | -76,817,000 | -51,745,000 | -175,609,000 | -143,501,000 | -127,748,000 | 763,368,000 | -112,588,000 | -107,186,000 | -92,239,000 | -79,277,000 | 30,546,000 | 138,697,000 | -53,614,000 | -48,323,000 | -47,356,000 | -50,574,000 | -38,284,000 | - |
EBT Margin | -42.5% | -0.58 | -0.41 | -0.75 | -0.72 | -0.76 | 0.39 | 0.41 | 0.50 | 0.61 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -230.5% | -116,591,000 | 89,347,000 | -112,152,000 | -77,740,000 | -53,065,000 | -179,217,000 | -141,248,000 | -127,153,000 | 759,225,000 | -113,163,000 | -107,039,000 | -92,439,000 | -79,656,000 | 30,542,000 | 138,423,000 | -53,699,000 | -48,408,000 | -47,590,000 | -50,711,000 | - | - |
Net Income Margin | -41.4% | -0.58 | -0.41 | -0.74 | -0.71 | -0.75 | 0.39 | 0.41 | 0.50 | 0.61 | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 212.6% | 109,031,000 | -96,811,000 | -41,974,000 | -136,800,000 | 5,740,000 | -150,589,000 | -95,221,000 | -118,378,000 | 778,553,000 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 9.4% | 2,439 | 2,230 | 2,087 | 2,197 | 2,244 | 2,243 | 2,353 | 2,463 | 2,606 | 2,752 | 2,822 | 2,900 | 1,958 | 1,828 | 1,485 | 1,047 | 1,007 | 1,067 | 721 | 494 | 498 |
Current Assets | 11.1% | 2,120 | 1,908 | 1,761 | 1,860 | 1,908 | 1,853 | 1,933 | 2,107 | 2,261 | 2,418 | 2,519 | 2,621 | 1,832 | 1,717 | 1,391 | 966 | 929 | 988 | 664 | 438 | 450 |
Cash Equivalents | 81.6% | 707 | 389 | 528 | 445 | 344 | 212 | 494 | 497 | 684 | 923 | 1,012 | 1,647 | 1,126 | 1,169 | 1,041 | 945 | 890 | 944 | 630 | 428 | 438 |
Net PPE | -3.1% | 147 | 152 | 156 | 159 | 162 | 164 | 166 | 165 | 157 | 138 | 106 | 75.00 | 52.00 | 42.00 | 38.00 | 34.00 | 32.00 | 31.00 | 21.00 | 20.00 | 19.00 |
Liabilities | 2.4% | 355 | 347 | 359 | 381 | 389 | 368 | 399 | 373 | 361 | 352 | 309 | 296 | 152 | 164 | 142 | 136 | 121 | 127 | 129 | 127 | 118 |
Current Liabilities | 9.4% | 119 | 109 | 111 | 133 | 147 | 121 | 151 | 120 | 114 | 120 | 96.00 | 100 | 83.00 | 94.00 | 84.00 | 75.00 | 55.00 | 57.00 | 80.00 | 31.00 | 28.00 |
Shareholder's Equity | 10.7% | 2,084 | 1,883 | 1,728 | 1,816 | 1,855 | 1,875 | 1,954 | 2,091 | 2,245 | 2,399 | 2,513 | 2,604 | 1,805 | 1,664 | 1,343 | 911 | 886 | 939 | 592 | 368 | 380 |
Retained Earnings | -11.7% | -1,116 | -999 | -1,089 | -976 | -899 | -846 | -735 | -560 | -375 | -195 | -54.67 | 72.00 | -686 | -573 | -466 | -374 | -294 | -224 | -255 | -393 | -339 |
Additional Paid-In Capital | 11.2% | 3,199 | 2,878 | 2,821 | 2,799 | 2,761 | 2,735 | 2,709 | 2,670 | 2,635 | 2,598 | 2,566 | 2,530 | 2,490 | 2,236 | 1,808 | 1,283 | 1,179 | 1,162 | 846 | 760 | 718 |
Shares Outstanding | 6.0% | 85.00 | 80.00 | 79.00 | 79.00 | 79.00 | 79.00 | 78.00 | 78.00 | 77.00 | 76.00 | 76.00 | 75.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 4,100 | - | - | - | 4,300 | - | - | - | 11,400 | - | - | - | 4,500 | - | - | - | 2,500 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 214.2% | 109,752 | -96,073 | -39,856 | -133,245 | 8,799 | -113,328 | -105,218 | -141,956 | -135,239 | -86,038 | -81,329 | 807,002 | -100,663 | -81,212 | -75,700 | -29,279 | -52,175 | 3,376 | 133,420 | -36,382 | -43,737 |
Share Based Compensation | 5.3% | 19,405 | 18,420 | 19,968 | 21,765 | 20,875 | 22,805 | 24,545 | 24,852 | 25,745 | 25,768 | 26,199 | 28,331 | 22,092 | 18,930 | 17,240 | 15,697 | 14,151 | 11,857 | 11,343 | 11,186 | 9,671 |
Cashflow From Investing | -20.1% | -97,800 | -81,453 | 121,348 | 216,923 | 117,829 | -175,532 | 87,464 | -56,072 | -114,515 | -8,716 | -565,180 | -293,636 | -167,898 | -204,244 | -330,330 | -3,605 | -2,991 | 7,057 | -2,461 | -2,174 | -1,097 |
Cashflow From Financing | 685.7% | 305,934 | 38,939 | 1,556 | 16,765 | 5,404 | 2,478 | 15,112 | 10,353 | 10,649 | 6,299 | 10,212 | 8,443 | 225,991 | 412,627 | 512,888 | 89,505 | 1,132 | 304,718 | 70,885 | 29,654 | 25,726 |
Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue: | |||
Total revenue | $ 371,206 | $ 1,198 | $ 914,963 |
Operating expenses: | |||
Research and development | 387,332 | 461,645 | 340,567 |
General and administrative | 76,162 | 102,464 | 99,690 |
Collaboration expense, net | 130,250 | 110,250 | 101,178 |
Total operating expenses | 593,744 | 674,359 | 541,435 |
(Loss) income from operations | (222,538) | (673,161) | 373,528 |
Other income | |||
Other income, net | 71,816 | 22,661 | 6,003 |
Total other income, net | 71,816 | 22,661 | 6,003 |
Net income (loss) before income taxes | (150,722) | (650,500) | 379,531 |
(Provision) benefit for income taxes | (2,888) | 325 | (1,870) |
Net (loss) income | (153,610) | (650,175) | 377,661 |
Foreign currency translation adjustment | 73 | (80) | (11) |
Unrealized gain (loss) on marketable securities | 17,487 | (10,500) | (4,973) |
Comprehensive (loss) income | $ (136,050) | $ (660,755) | $ 372,677 |
Net (loss) income per common share - basic | $ (1.94) | $ (8.36) | $ 4.97 |
Basic weighted-average common shares outstanding | 79,220,930 | 77,746,575 | 75,948,686 |
Net (loss) income per common share - diluted | $ (1.94) | $ (8.36) | $ 4.7 |
Diluted weighted-average common shares outstanding | 79,220,930 | 77,746,575 | 80,393,496 |
Collaboration Revenue [Member] | |||
Revenue: | |||
Total revenue | $ 370,000 | $ 436 | $ 913,081 |
Grant Revenue [Member] | |||
Revenue: | |||
Total revenue | $ 1,206 | $ 762 | $ 1,882 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 389,477 | $ 211,885 |
Marketable securities | 1,304,215 | 1,603,433 |
Accounts receivable | 200,000 | 0 |
Prepaid expenses and other current assets | 14,386 | 37,708 |
Total current assets | 1,908,078 | 1,853,026 |
Property and equipment, net | 151,945 | 163,634 |
Marketable securities, non-current | 1,973 | 53,130 |
Intangible assets, net | 16 | 71 |
Restricted cash | 11,591 | 11,635 |
Operating lease assets | 153,993 | 156,921 |
Other non-current assets | 1,975 | 4,640 |
Total assets | 2,229,571 | 2,243,057 |
Current liabilities: | ||
Accounts payable | 38,147 | 27,428 |
Accrued expenses | 45,335 | 77,682 |
Deferred revenue, current | 4,105 | 0 |
Accrued tax liabilities | 438 | 135 |
Operating lease liabilities | 15,625 | 15,842 |
Other current liabilities | 5,141 | 20 |
Total current liabilities | 108,791 | 121,107 |
Deferred revenue, non-current | 14,012 | 12,323 |
Operating lease liabilities, net of current portion | 223,007 | 228,179 |
Other non-current liabilities | 958 | 5,969 |
Total liabilities | 346,768 | 367,578 |
Commitments and contingencies (Note 9) | ||
Shareholders’ equity: | ||
Common shares, CHF 0.03 par value, 126,536,183 and 150,347,467 shares authorized at December 31, 2023 and 2022, respectively, 80,214,694 and 78,692,766 shares issued at December 31, 2023 and 2022, respectively, 80,044,378 and 78,512,450 shares outstanding at December 31, 2023 and 2022,respectively | 2,497 | 2,441 |
Treasury shares, at cost, 170,316 and 180,316 shares at December 31, 2023 and 2022, respectively | (62) | (63) |
Additional paid-in capital | 2,878,155 | 2,734,838 |
Accumulated deficit | (999,700) | (846,090) |
Accumulated other comprehensive income (loss) | 1,913 | (15,647) |
Total shareholders’ equity | 1,882,803 | 1,875,479 |
Total liabilities and shareholders’ equity | $ 2,229,571 | $ 2,243,057 |